Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Off-Label Litigation: Amarin Sues FDA In Bid To Promote Vascepa Fish Oil

This article was originally published in The Pink Sheet Daily

Executive Summary

First Amendment lawsuit is most recent challenge of agency’s promotional policies.

Advertisement

Related Content

Amarin Seeks ITC Action Against Products 'Cloaked' As Dietary Supplements
Amarin Seeks ITC Action Against Products 'Cloaked' As Dietary Supplements
Doctors Often Recommend Omega-3 Supplements For High Cholesterol – Survey
FDA Promises More Off-label Guidances As Part Of First Amendment Harmonization
The Era Of Billion Dollar Pharma Settlements

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS078548

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel